CoChat

Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo

Open access
Adekunle, Adeshina I., Pinkevych, Mykola, McGready, Rose, Luxemburger, Christine, White, Lisa J., Nosten, François, Cromer, Deborah, Davenport, Miles P. · 2015 · PLOS Neglected Tropical Diseases
Cited by 102

The DOI matches its Crossref record.

Abstract

The dynamics of Plasmodium vivax infection is characterized by reactivation of hypnozoites at varying time intervals. The relative contribution of new P. vivax infection and reactivation of dormant liver stage hypnozoites to initiation of blood stage infection is unclear. In this study, we investigate the contribution of new inoculations of P. vivax sporozoites to primary infection versus reactivation of hypnozoites by modeling the dynamics of P. vivax infection in Thailand in patients receiving treatment for either blood stage infection alone (chloroquine), or the blood and liver stages of infection (chloroquine + primaquine). In addition, we also analysed rates of infection in a study in Papua New Guinea (PNG) where patients were treated with either artesunate, or artesunate + primaquine. Our results show that up to 96% of the P. vivax infection is due to hypnozoite reactivation in individuals living in endemic areas in Thailand. Similar analysis revealed the around 70% of infections in the PNG cohort were due to hypnozoite reactivation. We show how the age of the cohort, primaquine drug failure, and seasonality may affect estimates of the ratio of primary P. vivax infection to hypnozoite reactivation. Modeling of P. vivax primary infection and hypnozoite reactivation provides important insights into infection dynamics, and suggests that 90-96% of blood stage infections arise from hypnozoite reactivation. Major differences in infection kinetics between Thailand and PNG suggest the likelihood of drug failure in PNG.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pntd.0003595

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 31

  1. K Mendis, 2001, The neglected burden of Plasmodium vivax malaria, The American journal of tropical medicine and hygiene, 64, 97, 10.4269/ajtmh.2001.64.97 · DOI · Paper page
  2. CA Guerra, 2010, The international limits and population at risk of Plasmodium vivax transmission in 2009, PLoS neglected tropical diseases, 4, e774, 10.1371/journal.pntd.0000774 · DOI · Paper page
  3. PW Gething, 2012, A long neglected world malaria map: Plasmodium vivax endemicity in 2010, PLoS Negl Trop Dis, 6, e1814, 10.1371/journal.pntd.0001814 · DOI · Paper page
  4. LH Miller, 1994, Malaria pathogenesis, Science, 264, 1878, 10.1126/science.8009217 · DOI · Paper page
  5. S Kitchen, 1938, The infection of reticulocytes by Plasmodium vivax, The American Journal of Tropical Medicine and Hygiene, 1, 347, 10.4269/ajtmh.1938.s1-18.347 · doi:10.4269/ajtmh.1938.s1-18.347
  6. A Arnott, 2012, Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination, Malar J, 11, 14, 10.1186/1475-2875-11-14 · DOI
  7. JK Baird, 2008, Real-world therapies and the problem of vivax malaria, New England Journal of Medicine, 359, 2601, 10.1056/NEJMe0808729 · DOI
  8. I Betuela, 2012, Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1–5 years of age, Journal of Infectious Diseases, 206, 1771, 10.1093/infdis/jis580 · DOI · Paper page
  9. C Luxemburger, 1999, Treatment of vivax malaria on the western border of Thailand, Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 433, 10.1016/S0035-9203(99)90149-9 · DOI
  10. AM McCollum, 2014, Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations, Malar J, 13, 67, 10.1186/1475-2875-13-67 · DOI
  11. C Koepfli, 2009, Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials, Journal of Infectious Diseases, 199, 1074, 10.1086/597303 · DOI · Paper page
  12. V Andrianaranjaka, 2013, Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar, Malar J, 12, 177, 10.1186/1475-2875-12-177 · DOI
  13. N Chen, 2007, Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, Journal of Infectious Diseases, 195, 934, 10.1086/512242 · DOI · Paper page
  14. M Imwong, 2007, Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites, Journal of Infectious Diseases, 195, 927, 10.1086/512241 · DOI · Paper page
  15. JK Baird, 2004, Primaquine therapy for malaria, Clinical infectious diseases, 39, 1336, 10.1086/424663 · DOI · Paper page
  16. C Koepfli, 2013, A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children, PLoS Negl Trop Dis, 7, e2403, 10.1371/journal.pntd.0002403 · DOI
  17. T Adak, 1998, Studies on the Plasmodium vivax relapse pattern in Delhi, India, Am J Trop Med Hyg, 59, 175, 10.4269/ajtmh.1998.59.175 · doi:10.4269/ajtmh.1998.59.175
  18. NJ White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malaria journal, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
  19. P Shute, 1976, A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period, Transactions of the Royal Society of Tropical Medicine and Hygiene, 70, 474, 10.1016/0035-9203(76)90132-2 · DOI
  20. AT Bright, 2014, A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings, PLoS Negl Trop Dis, 8, e2882, 10.1371/journal.pntd.0002882 · DOI · Paper page
  21. FCF de Araujo, 2012, Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection, PloS one, 7, e49871, 10.1371/journal.pone.0049871 · doi:10.1371/journal.pone.0049871
  22. M Imwong, 2012, The first Plasmodium vivax relapses of life are usually genetically homologous, Journal of Infectious Diseases, 205, 680, 10.1093/infdis/jir806 · DOI · Paper page
  23. P Venkatesan, 2003, Seasonality of presentation of imported Plasmodium vivax malaria in Birmingham, UK, Trans R Soc Trop Med Hyg, 97, 550, 10.1016/S0035-9203(03)80023-8 · doi:10.1016/s0035-9203(03)80023-8
  24. C Koepfli, 2013, A high force of Plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in Papua New Guinean children, PLoS neglected tropical diseases, 7, e2403, 10.1371/journal.pntd.0002403 · DOI
  25. J Xainli, 2002, Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans, The Journal of Immunology, 169, 3200, 10.4049/jimmunol.169.6.3200 · DOI
  26. NM Douglas, 2011, Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 52, 612, 10.1093/cid/ciq249 · DOI · Paper page
  27. M Mayxay, 2004, Mixed-species malaria infections in humans, Trends in parasitology, 20, 233, 10.1016/j.pt.2004.03.006 · DOI · Paper page
  28. JW Bennett, 2013, Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria, New England Journal of Medicine, 369, 1381, 10.1056/NEJMc1301936 · DOI · Paper page
  29. BS Pybus, 2012, CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine, Malar J, 11, 259, 10.1186/1475-2875-11-259 · DOI
  30. J Sistonen, 2007, CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure, Pharmacogenetics and genomics, 17, 93, 10.1097/01.fpc.0000239974.69464.f2 · DOI · Paper page
  31. N von Ahsen, 2010, CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess, International journal of molecular epidemiology and genetics, 1, 310

Cited by

Metadata

Authors
Adekunle, A. I., Pinkevych, M., McGready, R., Luxemburger, C., White, L. J., Nosten, F., Cromer, D., & Davenport, M. P.
Venue
PLOS Neglected Tropical Diseases
Published
2015-03-17
Volume
9
Issue
3
Pages
e0003595
ISSN
  • 1935-2727 (ISSN-L)
  • 1935-2735
OpenAlex
W2013411967
Cited by
102
References
0
FWCI
9.06
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.